A novel mechanism causing bradycardia during right lung pleurodesis.
作者信息
Markewich Stephen D, Stanger Ryan P, Lucas Warner J, Feins Richard H, Kyle Robert W, Zvara David A
出版信息
Anesth Analg. 2009 Oct;109(4):1352-3. doi: 10.1213/ane.0b013e3181b3b5ae.
PMID:19762774
Abstract
摘要
相似文献
1
A novel mechanism causing bradycardia during right lung pleurodesis.
Anesth Analg. 2009 Oct;109(4):1352-3. doi: 10.1213/ane.0b013e3181b3b5ae.
2
[Adverse effects of aerosol therapy with freon propellants in patients with asthma and cystic fibrosis].
Ugeskr Laeger. 1979 Oct 15;141(42):2892-3.
3
Cardiovascular effects of acute and chronic inhalations of fluorocarbon 12 in rabbits.
J Pharmacol Exp Ther. 1975 Jan;192(1):129-35.
4
[Problems of cardiotoxicity of propellants].
Arh Hig Rada Toksikol. 1974;25(3):349-58.
5
Aerosol consensus statement. Consensus Conference on Aerosol Delivery.
Chest. 1991 Oct;100(4):1106-9.
6
The environmental impact of chlorofluorocarbon use in metered dose inhalers.
Chest. 1991 Oct;100(4):1101-2. doi: 10.1378/chest.100.4.1101.
7
Bronchial reactions to aerosol inhalant vehicle.
Br Med J. 1976 May 29;1(6021):1319-20. doi: 10.1136/bmj.1.6021.1319.
8
Are aerosol sprays hazardous?
Am Rev Respir Dis. 1975 Oct;112(4):485-9. doi: 10.1164/arrd.1975.112.4.485.
9
Are freon propellants inert?
N Y State J Med. 1974 Oct;74(11):1939-41.
10
Toward international consensus on clinical aerosol administration.
Chest. 1991 Oct;100(4):1100-1. doi: 10.1378/chest.100.4.1100.
引用本文的文献
1
Pleural transudate: pathophysiology during superior vena cava syndrome.
ERJ Open Res. 2019 Feb 25;5(1). doi: 10.1183/23120541.00251-2018. eCollection 2019 Feb.
Zotero 插件